Biotech Values

[DewDiligence]

AGN scores a reversal in appeal of Latisse case:

http://www.reuters.com/article/2011/05/24/allergan-patent-idUSN2425921620110524

Allergan accused a long list of companies, including Athena Cosmetics, Cosmetic Alchemy LLC and Stella International LLC, of either infringing its patented treatment for eyelash growth or inducing others to infringe.

The U.S. District Court for the Central District of California dismissed the case, saying that Allergan failed to prove that it was injured by any infringement. The appeals court, which specializes in patent cases, disagreed. "Here, Allergan has plainly alleged an economic injury that was the result of an unfair business practice," the appeals court said.

Competition from illicit knockoffs is part of the reason that annualized Latisse sales are only $100M (#msg-62751639).